Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | BARD1 |
| Variant | Q564* |
| Impact List | nonsense |
| Protein Effect | loss of function |
| Gene Variant Descriptions | BARD1 Q564* results in a premature truncation of the Bard1 protein at amino acid 564 of 777 (UniProt.org). Q564* confers a loss of function to Bard1 as demonstrated by decreased homology-directed DNA repair activity in cell culture (PMID: 30925164), telomere abnormalities in patient cells, and increased sensitivity to olaparib and cisplatin treatment in cultured cells (PMID: 37688570). |
| Associated Drug Resistance | |
| Category Variants Paths |
BARD1 mutant BARD1 inact mut BARD1 Q564* |
| Transcript | NM_000465.4 |
| gDNA | chr2:g.214745842G>A |
| cDNA | c.1690C>T |
| Protein | p.Q564* |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_000465 | chr2:g.214745842G>A | c.1690C>T | p.Q564* | RefSeq | GRCh38/hg38 |
| NM_000465.3 | chr2:g.214745842G>A | c.1690C>T | p.Q564* | RefSeq | GRCh38/hg38 |
| XM_047445350.1 | chr2:g.214745842G>A | c.1690C>T | p.Q564* | RefSeq | GRCh38/hg38 |
| NM_000465.4 | chr2:g.214745842G>A | c.1690C>T | p.Q564* | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|